Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Newron Pharmaceuticals

Newron Pharmaceuticals
1999 FOUNDED
PUBLIC STATUS
21-30 EMPLOYEES
NWRN STOCK SYMBOL
2 INVESTMENTS
$7.14 SHARE PRICE (As of Monday Closing)
Description

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Stock Exchange
SWX
Primary Office
  • Via Ludovico Ariosto 21
  • Bresso
  • 20091 Milan
  • Italy

+39 02 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Newron Pharmaceuticals’s full profile, request a free trial.

Newron Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$5.36 - $9.78 $127M $7.63 -$1.38 24.3K 17.8M

Newron Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 64,926 43,093 159,758 243,381
Revenue 4,847 4,750 15,144 5,322
EBITDA (24,541) (17,758) (6,058) (16,899)
Net Income (24,525) (17,742) (5,957) (16,854)
Total Assets 68,037 68,326 87,607 59,517
Total Debt 10,851 383
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Newron Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Newron Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Newron Pharmaceuticals Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avanir Pharmaceuticals Corporate Backed or Acquired Aliso Viejo, CA 000 0000 000000&0 0000
00000000000 000000 Private Equity-Backed Langenfeld, Germany 000 000000000000
0000000 Formerly VC-backed Emeryville, CA 00 00000 000000000 00000
0000000 Formerly VC-backed Menlo Park, CA 000 00000 000000000 00000
0000000000 Private Debt Financed Aachen, Germany 0000 000000000
To view this company’s complete list of competitors, request access »

Newron Pharmaceuticals Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 13-Jun-2012 000000000000000000 000.00 Therapeutic Devices
Hunter-Fleming 29-Apr-2008 Merger/Acquisition 00.00 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Newron Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Newron Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Newron Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
Stefan Weber Chief Executive Officer, Board Member & Managing Director
Dennis Dionne Executive Director of Commercial Operations
Marco Caremi Executive Vice President, Business Development
Roberto Galli Vice President, Finance
Ravi Anand Chief Medical Officer

Newron Pharmaceuticals Board Members (8)

Name Representing Role Since Contact
Info
000000 000000000 00.0 Self Board Member 000 0000
0000000 00000000 00.0 Self Chairman of the Company's Audit and Risk Committee and member of the Compensation and Nomination Com 000 0000
000000 0000000 00.0 Self Non-Executive Board Member 000 0000
000000 0000000 00 Newron Pharmaceuticals Chairman 000 0000

4 Former Board Members

You’re viewing 4 of 8 board members. Get the full list »